Factor woes prove need for better timing – QuantZ’s Sharma
Investors should switch between factors as alphas change, says quant
On the morning of November 9, 2020, when US pharmaceutical company Pfizer released the first set of data about its Covid-19 vaccine, Milind Sharma, a former prop trader at Deutsche Bank and RBC Capital Markets, noted an “off the chart” move in his factor heat maps, which measure the performance of quant factors such as value or momentum.
“It was just staggering,” he says. The market reversal turned winners into overnight losers and losers into winners. “Never before has momentum crashed more
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.risk.net/subscribe
You are currently unable to print this content. Please contact [email protected] to find out more.
You are currently unable to copy this content. Please contact [email protected] to find out more.
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. Printing this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/
If you would like to purchase additional rights please email [email protected]
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. Copying this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/
If you would like to purchase additional rights please email [email protected]
